Dr Juliet Brock

Dr Juliet Brock specialises in the non-surgical management of central nervous system tumours.

Towards the end of her Clinical Oncology Training, she undertook a post-graduate research degree at the Institute of Cancer Research and Royal Marsden Hospital focussing on technical radiotherapy. Dr Brock was subsequently appointed to a senior clinical fellow post specialising in the management of brain metastases, in particular the use of stereotactic radiotherapy (SRS).

She was appointed to a consultant post treating CNS and lung cancer at the Sussex Cancer Centre in 2011. During that post she remained active in clinical research, with a particular interest in glioma in the older person. Dr Brock supervised a research fellow undertaking an MD and has formed a successful national research collaboration, as well as being a local principal investigator for brain tumour trials. In 2022 she was appointed chair of a National Cancer Research Institute (NCRI) brain tumour working group tasked with improving outcomes for older and frail brain tumour patients.

In September 2022, Dr Brock took up a new consultant Neuro-oncology post at Oxford University Hospitals. Her aim is to provide excellent compassionate care to all patients with central nervous system tumours, delivering high quality technical radiotherapy and evidence-based systemic treatment. A specific focus will be improving the multi-disciplinary management of brain metastases.